BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 9579565)

  • 1. p53 mutations in sweat gland carcinomas.
    Biernat W; Peraud A; Wozniak L; Ohgaki H
    Int J Cancer; 1998 May; 76(3):317-20. PubMed ID: 9579565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p53 expression in sweat gland tumors.
    Biernat W; Woźniak L
    Pol J Pathol; 1996; 47(1):3-6. PubMed ID: 8705267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A potential role for targeted therapy in a subset of metastasizing adnexal carcinomas.
    Dias-Santagata D; Lam Q; Bergethon K; Baker GM; Iafrate AJ; Rakheja D; Hoang MP
    Mod Pathol; 2011 Jul; 24(7):974-82. PubMed ID: 21423156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA image cytometry in malignant and benign sweat gland tumours.
    Vogelbruch M; Böcking A; Rütten A; Kapp A; Kiehl P
    Br J Dermatol; 2000 Apr; 142(4):688-93. PubMed ID: 10792218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Malignant sweat gland tumours: an update.
    Cardoso JC; Calonje E
    Histopathology; 2015 Nov; 67(5):589-606. PubMed ID: 26114606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic changes in sweat gland carcinomas.
    Takata M; Hashimoto K; Mehregan P; Lee MW; Yamamoto A; Mohri S; Ohara K; Takehara K
    J Cutan Pathol; 2000 Jan; 27(1):30-5. PubMed ID: 10660129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p53 mutations in sporadic adrenocortical tumors.
    Ohgaki H; Kleihues P; Heitz PU
    Int J Cancer; 1993 May; 54(3):408-10. PubMed ID: 8509216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Next-generation sequencing implicates oncogenic roles for p53 and JAK/STAT signaling in microcystic adnexal carcinomas.
    Chan MP; Plouffe KR; Liu CJ; Palanisamy N; Carskadon S; Zhao L; Nazarian RM; Durham AB; Johnson TM; Andea AA; Patel RM; Lowe L; Fullen DR; Brown NA; Tomlins SA; Udager AM; Harms PW
    Mod Pathol; 2020 Jun; 33(6):1092-1103. PubMed ID: 31857679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53 gene mutations in oropharyngeal carcinomas: a comparison of solitary and multiple primary tumours and lymph-node metastases.
    Zariwala M; Schmid S; Pfaltz M; Ohgaki H; Kleihues P; Schäfer R
    Int J Cancer; 1994 Mar; 56(6):807-11. PubMed ID: 8119770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bax expression in benign and malignant thyroid tumours: dysregulation of wild-type P53 is associated with a high Bax and P21 expression in thyroid carcinoma.
    Hermann S; Sturm I; Mrozek A; Klosterhalfen B; Hauptmann S; Dörken B; Daniel PT
    Int J Cancer; 2001 Jun; 92(6):805-11. PubMed ID: 11351299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Sweat gland carcinomas of the skin].
    Rütten A; Requena L
    Hautarzt; 2008 Feb; 59(2):151-60. PubMed ID: 18214401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53 mutations in childhood thyroid tumours from Belarus and in thyroid tumours without radiation history.
    Smida J; Zitzelsberger H; Kellerer AM; Lehmann L; Minkus G; Negele T; Spelsberg F; Hieber L; Demidchik EP; Lengfelder E; Bauchinger M
    Int J Cancer; 1997 Dec; 73(6):802-7. PubMed ID: 9399655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. KIT (CD117) Expression in Benign and Malignant Sweat Gland Tumors.
    Nishida H; Daa T; Kashima K; Arakane M; Urabe S; Yoshikawa Y; Gamachi A; Yokoyama S
    Am J Dermatopathol; 2015 Dec; 37(12):898-905. PubMed ID: 25634571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical demonstration of myoepithelial cells in sweat gland carcinomas.
    Wach F; Hein R; Kuhn A; Landthaler M; Krieg T; Eckert F
    Br J Dermatol; 1994 Apr; 130(4):432-7. PubMed ID: 8186107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vulvar sweat gland carcinomas.
    Wick MR; Goellner JR; Wolfe JT; Su WP
    Arch Pathol Lab Med; 1985 Jan; 109(1):43-7. PubMed ID: 2982338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p53 mutations in all stages of thyroid carcinomas.
    Zou M; Shi Y; Farid NR
    J Clin Endocrinol Metab; 1993 Oct; 77(4):1054-8. PubMed ID: 8408453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene p53 mutations are restricted to poorly differentiated and undifferentiated carcinomas of the thyroid gland.
    Donghi R; Longoni A; Pilotti S; Michieli P; Della Porta G; Pierotti MA
    J Clin Invest; 1993 Apr; 91(4):1753-60. PubMed ID: 8473515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Demonstration of ras and p53 gene mutations in carcinomas in the forestomach and intestine and soft tissue sarcomas induced by N-methyl-N-nitrosourea in the rat.
    Matsumoto K; Iwase T; Hirono I; Nishida Y; Iwahori Y; Hori T; Asamoto M; Takasuka N; Kim DJ; Ushijima T; Nagao M; Tsuda H
    Jpn J Cancer Res; 1997 Feb; 88(2):129-36. PubMed ID: 9119740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malignant Sweat Gland Tumors.
    Ahn CS; Sangüeza OP
    Hematol Oncol Clin North Am; 2019 Feb; 33(1):53-71. PubMed ID: 30497677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of p53 gene mutations in human endometrial carcinomas.
    Honda T; Kato H; Imamura T; Gima T; Nishida J; Sasaki M; Hoshi K; Sato A; Wake N
    Int J Cancer; 1993 Apr; 53(6):963-7. PubMed ID: 8473053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.